Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France.

Reproductive Health After Kidney Transplantation: Insights Into Infertility and Assisted Techniques.

Corrigendum to "Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline" [Fertil Steril 2024;121:230-45].

Pre-trigger risk scoring for moderate-to-severe ovarian hyperstimulation syndrome in in vitro fertilization and intracytoplasmic sperm injection cycles.

Views on outpatient paracentesis and GnRH antagonists for ovarian hyperstimulation syndrome: a qualitative study of patients and healthcare professionals.

Association of Sleeve Gastrectomy With the Management of Ovarian Hyperstimulation Syndrome: A Retrospective Study.

Transcriptomic Profiling Reveals Urokinase-Type Plasminogen Activator-Mediated Regulation of Metabolic Competence and Cumulus Expansion During Mouse Oocyte In Vitro Maturation.

C-Phycocyanin ameliorates ovarian hyperstimulation syndrome by mitigating inflammation and enhances fertility in an OHSS mouse model.

ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025†.

Flavonoids and polycystic ovary syndrome.

Clinical practice guideline for female fertility preservation.

Vitamin D supplementation before in vitro fertilisation in women with polycystic ovary syndrome: multicentre, double blind, placebo controlled, randomised clinical trial.

The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review.

Unlocking new horizons in egg donation: clinical and logistical benefits of double ovarian stimulation.

Prostaglandin F2α for preventing and treating severe ovarian hyperstimulation syndrome: a targeted therapy hidden in plain sight.

Minimal Dose Paradigm in IUI Stimulation for Unexplained Infertility: Letrozole-Initiated Late Gonadotropin Protocol.

Exploratory pilot trial of astaxanthin supplementation in PCOS patients at risk of OHSS with focus on RAGE-NFκB pathway.

The efficacy and safety of Cangfu Daotan decoction in the treatment of infertility associated with polycystic ovary syndrome: a systematic review and meta-analysis.

Integrated Prediction System for Individualized Ovarian Stimulation and Ovarian Hyperstimulation Syndrome Prevention: Algorithm Development and Validation.

A randomized controlled trial comparing combination of letrozole and clomiphene citrate or letrozole alone for ovarian stimulation in infertile women.

The importance of ovary-immune interactions in the context of age and disease.

Sphingosine-1-phosphate in ovarian hyperstimulation syndrome: Biomarker promise and therapeutic peril.

Comparing ovulation induction strategies for unexplained infertility: protocol for a systematic review and network meta-analysis.

Efficacy of Stop GnRH-Agonist/Antagonist versus GnRH-Antagonist Protocols in In Vitro Fertilization Cycles of Patients with Polycystic Ovary Syndrome: A Pilot Randomized Controlled Trial.

Right Middle Cerebral Artery Occlusion Following Ovarian Hyperstimulation Syndrome: A Case Study.

Comparison of in vitro fertilization outcomes between patients with and without polycystic ovary syndrome.

Multiple Pregnancy (Quintuplets) and Treatment Considerations for Critical Ovarian Hyperstimulation Syndrome.

Overcoming oral medication allergy and cervical stenosis in an anovulatory in vitro fertilization patient: a case report.

Ovarian hyperstimulation syndrome in a premature newborn.

The Trigger in IVF Cycles: Molecular Pathways and Clinical Implications.

[Chinese Expert Consensus on GnRH-a in Obstetrics and Gynecology].

Effects of high basal luteinizing hormone levels on in vitro fertilization/intra-cytoplasmic injection outcomes in polycystic ovarian syndrome: a retrospective study.

Comparative study of two ovulation induction therapies and laparoscopic ovarian drilling on clinical outcomes in women with clomiphene citrate-resistant polycystic ovary syndrome.

Fertility preservation in endometriosis: current strategies and outcomes.

The impact of follicle-stimulating hormone receptor mutations on female ovarian function and pregnancy outcomes: a systematic review†.

Effect of oral contraceptive pretreatment on IVF outcomes in women with polycystic ovary syndrome using a long GnRH agonist protocol.

Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation.

Impact of assisted reproductive therapy on kidney and pregnancy outcomes in women with early-stage chronic kidney disease: a longitudinal analysis.

Pregnancy-Related Acute Kidney Injury in Spontaneous Ovarian Hyperstimulation Syndrome: A Case Report.

Investigating the effects of melatonin on structural and vascular changes in an experimentally induced ovarian hyperstimulation syndrome model : Effects of melatonin on experimentally induced ovarian hyperstimulation syndrome.

Innovations in assisted reproductive technologies: evaluating efficacy, safety, and long-term outcomes in female infertility.

Real-World Effectiveness and Safety of Recombinant Human Follicle-Stimulating Hormone (rhFSH) in Infertile Women undergoing Assisted Reproductive Technology (ART): A Korean Nationwide Cohort Study.

Assisted reproductive technology and reproductive, perinatal, and maternal outcomes: evidence from an umbrella review of systematic reviews with meta-analyses of randomized controlled trials.

Undetectable Serum Level of Anti-Müllerian Hormone (AMH) in a Woman with an Unpredictable Hyper-Response During Controlled Ovarian Stimulation for an IVF-ICSI Program: Case Report.

The Effect of Retinoic Acid and Bevacizumab on Ovarian Hyperstimulation Syndrome.

The Evolution of In Vitro Fertilization Practices in Saudi Arabia: Historical Perspectives and Future Directions.

Severe Ovarian Hyperstimulation Syndrome (OHSS) After Gonadotrophin Releasing Hormone Agonist (GnRHa) Triggering.

2,000 IU hCG is the optimal dose in a dual hCG/GnRH agonist trigger to achieve comparable pregnancy rates to hCG alone in fresh embryo transfers.

Fibrinogen and cytokines as biomarkers of ovarian hyperstimulation syndrome in women undergoing assisted reproductive technology treatment: A prospective cohort study.

Comparative study between calcium gluconate with diosmin, cabergoline, and cabergoline with diosmin in prevention of ovarian hyperstimulation syndrome in high-risk women undergoing intracytoplasmic sperm injection (ICSI) procedures.

Risk factors and clinical outcomes of late-onset severe ovarian hyperstimulation syndrome in advanced maternal age women undergoing fresh embryo transfer.

Spontaneous ovarian hyperstimulation in a nonpregnant woman with PCOS: a rare case highlighting FMN2 missense mutation and androgen receptor gene deletion.

The Effect of Bazedoxifene and Fulvestrant for Preventing Ovarian Hyperstimulation Syndrome: An Experimental Study.

Real-World Safety and Effectiveness of Ganirelix for Ovarian Stimulation in Chinese Women: A Multicenter, Prospective, Single-Arm, Observational Study.

Wenyang Lishui Formula Ameliorates Symptoms of Ovarian Hyperstimulation Syndrome: A Prospective Cohort Study.

Pelvic Puzzles: Imaging Non-Traumatic Emergencies of the Female Pelvis: A Comprehensive Review.

Growth Hormone's Impact on Oxidative Stress, Ovarian Response, and In Vitro Fertilization in Polycystic Ovary Syndrome Across Different Ages.

Clinical Outcomes of High-Dose Follitropin Delta in POSEIDON (Patient-Oriented Strategies Encompassing Individualized Oocyte Number) Group 4: An Exploratory Case Series on Follicular Efficiency and Embryo Development.

Association of Follicular Distribution Patterns in Polycystic Ovaries with Clinical Outcomes in Assisted Reproductive Technology Cycles: A Prospective Cohort Study.

Natural conception complicated by spontaneous ovarian hyperstimulation syndrome in the setting of severe primary hypothyroidism: A case series.

Characterization of the secretory profile of gonadotroph pituitary tumors.

Advances in human oocyte in vitro maturation: current status and future perspectives: a narrative review.

Oocyte maturation triggers in high-responders: a report on 1,217 consecutive cycles.

Prevention of ovarian hyperstimulation syndrome: optimizing habitual stimulation strategies.

Impact of gonadotropin selection on risk of ovarian hyperstimulation syndrome in predicted high responders: a Menopur in Gonadotropin-releasing hormone Antagonist Single Embryo Transfer-High Responder trial analysis.

Time to pregnancy in young women with high response to controlled ovarian stimulation undergoing fresh transfer vs. a freeze-all strategy after in vitro fertilization treatment-a nationwide register-based cohort study.

Histological, Immunohistochemical, and Biochemical Evaluation of the Effect of Berberine on Ovarian Hyperstimulation Syndrome in Rats.

Comparison of efficacy, safety, and economy of recombinant and urinary follicle-stimulating hormone in women with a predicted normal response undergoing assisted reproductive technology.

Letrozole at the Crossroads of Efficacy and Fetal Safety in Ovulation Induction: A Narrative Review.

Synchronised approach for intrauterine insemination in subfertile couples.

Effectiveness and safety of follitropin delta in routine clinical practice in the Nordics and Switzerland (the NORSOS study): a prospective non-interventional study.

Dual trigger vs. gonadotropin-releasing hormone agonist trigger for elective fertility preservation: a randomized controlled trial.

Ovarian hyperstimulation revealing a functional gonadotroph adenoma: a case report.

Advanced high-grade serous carcinoma of the ovary after IVF treatment in a 38-year-old nulligravida: A case report of diagnostic challenges in the presence of OHSS.

Expression of concern 'Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial' [Fertil Steril 2015; 103:101-5].

Correlation Between Fertility Stress, Psychological Capital, and Conjugal Communication Patterns in Hospitalized Patients with Ovarian Hyperstimulation Syndrome During in vitro Fertilization-Embryo Transfer Cycles.

Clinical outcomes from assisted reproductive technology in predicted hyper-responders: a narrative review.

Severe, prolonged primary hypothyroidism causing ovarian hyperstimulation: an adult presentation (Van Wyk-Grumbach syndrome).

Combination of Continuous Use of Oral Clomiphene Citrate with Injectable Gonadotropins for Ovarian Stimulation: A Single-Center Study.

Comparison of clinical outcomes between flexible antagonist protocol and long luteal phase protocol in patients with normal ovarian reserve function: a prospective cohort study.

Is the risk of ovarian hyperstimulation syndrome adequately addressed in high anti-Müllerian hormone and PCOS patients undergoing IVF?

The influence of serum luteinising hormone concentrations post GnRH agonist trigger on metaphase II oocytes in IVF/ICSI cycles.

Electroacupuncture Improves Pregnancy Outcomes of Assisted Reproduction and Mitochondrial Function of Granulosa Cells in Patients with Polycystic Ovary Syndrome of Phlegm-Dampness Syndrome.

Comparing the Outcomes of In-Vitro Fertilization in Same-Sex Female Couples Using Their Partner's Egg Versus Their Own Egg: A Systematic Review.

Risk prediction models for ovarian hyperstimulation syndrome: a systematic review and meta-analysis.

Spontaneous Ovarian Hyperstimulation Syndrome and Hyperprolactinemia due to Primary Hypothyroidism: An Adolescent Case Report.

Ovarian stimulation protocols in fresh cycles and in elective freeze-all cycles.

A comparison of the effects of progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in assisted reproductive technology: a systematic review and meta-analysis.

Severe Early-onset Ovarian Hyperstimulation Syndrome with Isolated Pleural Effusion following Agonist Trigger in Gonadotropin-releasing Hormone Antagonist Cycle: A Case Report.

In Vitro Fertilization in Africa: Mild Versus Conventional Antagonist Ovarian Stimulation Protocols in Expected Normal Responders Undergoing IVF/ICSI: A Cohort Study From Ethiopia.

The Double-Edged Nature of the Gonadotropin-Releasing Hormone Agonist (GnRHa) Long Protocol: A Case of Paradoxical Ovarian Hyperstimulation During the Expected Downregulation Phase.

Ovarian stimulation with follitropin delta is safe and effective: results from the RITA randomized, double-blind, placebo-controlled trials.

Impact of Elevated Oestrogen Levels on hCG Trigger Day on Clinical Pregnancy Outcome and OHSS Incidence in Long-Acting GnRHa Down-Regulated IVF/ICSI-ET Cycles.

Successful delivery in a patient with ovarian hyperstimulation syndrome complicated by deep vein thrombosis: A case report.

The roles of MAPK signaling pathway in ovarian folliculogenesis.

Analysis of couple communication patterns as a mediator of fertility-related stress and psychological capital in women with severe ovarian hyperstimulation syndrome after embryo transfer.

Curcumin alleviates ovarian hyperstimulation syndrome in the rat model via inhibiting the nuclear factor kappa B/hypoxia-inducible factor-1α signaling pathway.

Gonadotropin Releasing Hormone-Antagonist Protocol (GnRH-ant) Combined Letrozole (LE) for Expected High Ovarian Responders (HOR): a Cohort Study.

Ovarian stimulation with follitropin delta for in vitro fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial).

Bilateral atypical ovarian masses: don't overlook a functional gonadotropic pituitary adenoma.

Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.

Effect of GnRH antagonist pretreatment before controlled ovarian stimulation in antagonist protocol for infertile women with PCOS undergoing IVF/ICSI: A propensity score matching analysis.

Corrigendum to "A rare presentation of isolated right-sided pleural effusion in the context of ovarian hyperstimulation syndrome: A case report" [Case Reports in Women's Health 32 (2021) e00347].

Acute Kidney Injury in Endocrine Emergencies.

Effect of Nifedipine in Preventing Ovarian Hyperstimulation Syndrome through TRPC1 Ion Channel Inhibition.

Association between ovarian hyperstimulation syndrome and adverse obstetric and neonatal outcomes in Korea: a nationwide health insurance database study.

Optimizing Oocyte Quality in Polycystic Ovary Syndrome (PCOS): The Impact of Neurotrophin-4 in In Vitro Maturation Protocols.

The impact of hCG trigger versus dual trigger on reproductive outcomes in elderly infertile women: a retrospective cohort study.

Association of long-term PM2.5 and its components exposure with ovarian hyperstimulation syndrome risk in assisted reproductive technology patients.

Undetected pregnancies in luteal phase stimulation - could they prevent ovarian hyperstimulation syndrome becoming a complication of the past?

A genetically engineered mouse model for ovarian hyperstimulation syndrome.

Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial.

Spontaneous Ovarian Hyperstimulation Syndrome in Natural Conception: A Case Report.

Potential therapeutic targets for ovarian hyperstimulation syndrome revealed by proteome-wide mendelian randomization and colocalization analysis.

Visualization analysis of ovarian hyperstimulation syndrome based on bibliometrics.

Analysis of emotional fluctuations in infertile women during ART treatment: the impact of ovarian hyperstimulation.

The Therapeutic Potential of EGCG and Pro-EGCG in Mitigating Ovarian Hyperstimulation Syndrome: Unraveling the Modulatory Mechanism through the VEGF Pathway.

DNA methylation landscapes of in vitro matured oocytes retrieved during endoscopic gynaecological procedures.

Impact of ovarian hyperstimulation syndrome on intracytoplasmic sperm injection outcomes in poly-cystic ovarian syndrome women: A cross-sectional study.

Just the facts: ovarian hyperstimulation syndrome - a primer for emergency physicians.

Imaging in Acute Obstetric Conditions: A Pictorial Essay.

Spontaneous ovarian hyperstimulation syndrome mimicking ovarian cancer in a nonpregnant woman: A case report and literature review.

GnRH ability to release FSH and LH in women with functional hypothalamic amenorrhea: a retrospective cohort study about women with and without polycystic ovarian morphology.

Ovarian hyperstimulation syndrome - a complication of the past.

Renewing ovarian stimulation.

Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004-2024).

Ovarian hyperstimulation syndrome in a patient on tamoxifen therapy.

Impact of different endometrial preparation protocols on pregnancy outcomes in patients at high risk for ovarian hyperstimulation syndrome: a propensity score matched retrospective cohort study.

Mendelian randomization study reveals causal associations between plasma metabolites, immune cell phenotypes, and ovarian hyperstimulation syndrome.

Development and externally validated prediction model of individualization of FSH starting dose in the depot GnRH agonist protocol for the early follicular phase.

Is There An Association between Dyslipidemia and The Risk of Ovarian Hyperstimulation Syndrome in A Population of Non-Obese Polycystic Ovary Syndrome Patients? A Cross-Sectional Study.

Randomized controlled trial to evaluate the impact of follicle priming on IVM outcomes in women with polycystic ovaries: CFA versus FSH-B.

Gonadotropins for ovulation induction in women with polycystic ovary syndrome.

Ambient temperature and ovarian hyperstimulation syndrome: An observational study.

Minimising OHSS in women with PCOS.

Pharmacogenetic analysis using artificial intelligence (AI) to identify polymorphisms associated with sub-optimal ovarian response and hyper-response.

Effect of different combinations of serum antimüllerian hormone levels and body mass index on pregnancy outcomes in women with polycystic ovary syndrome.

Lower serum level of hypoxia-inducible factor 1alpha during controlled ovarian stimulation is related to the higher risk of developing ovarian hyperstimulation syndrome.

Efficacy and safety of simplified follitropin delta dosing in women undergoing intrauterine insemination in Indonesia.

The treatment of adenomyosis-induced ovarian hyperstimulation syndrome with leuprolide.

Ovarian Hyperstimulation Syndrome Following In-Vitro Fertilization: A Case Report.

Cabergoline Use and Pregnancy Outcomes: A Systematic Review.

The application value of ultrasound in ovarian hyperstimulation syndrome and literature review.

Nomogram model to predict the risk of moderate to severe ovarian hyperstimulation syndrome of long protocol group in fresh cycle.

Unusual ovarian hyperstimulation syndrome presentation: Pleural effusion without ascites. A case report.

A retrospective study "myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.".

High-dose estrogen impairs demethylation of H3K27me3 by decreasing Kdm6b expression during ovarian hyperstimulation in mice.

Freeze-all indications in women with subfertility undergoing IVF: a cohort study.

Ovarian Hyperstimulation secondary to clomiphene citrate resulting in ovarian torsion: A rare report.

Bilateral massive bloody pleural effusions as a rare presentation of ovarian hyperstimulation syndrome: A case report and literature review.

Trends in fertility preservation treatments in Japan until 2023: analysis of the Japan Oncofertility Registry.

Fertility stimulation protocols in women with cancer.

Benign obstetric and gynaecological diseases associated with pleural effusion: a narrative review.

Risk of Thrombosis in Women Undergoing In Vitro Fertilization: A Narrative Review.

Effects of 100 IU versus 150 IU hCG supplementation on oocyte and embryo quality in patients aged ≥ 35 years: a propensity score-matched analysis.

[New treatment strategies in assisted reproduction].

The Role of GnRH Agonist Therapy and Hysterosalpingography (HSG) in Diagnosing and Treating Tubal Factor Infertility.

In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.

Follicular fluid meiosis activating sterol supplementation enhances oocyte maturation and fertilization in a microfluidic system: A lab trial study.

Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes.

Cost-Effectiveness and Clinical Outcomes of Controlled Ovarian Stimulation With Follitropin Delta and Follitropin Alfa: A Retrospective Study.

Triggering final follicular maturation for IVF cycles.

Controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: study protocol for a randomised controlled trial.

Oocyte donors' physical outcomes and psychosocial experiences: a mixed-methods study.

Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.

Oocyte yield and live birth rate after follitropin delta dosing and fresh embryo transfer: an individual patient data meta-analysis.

Biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART: a systematic review and meta-analysis.

A FSH-secreting pituitary adenoma discovered after ovarian hyperstimulation syndrome: a case report, illustrating pitfalls in the interpretation of serum FSH levels.

Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis.

Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis.

Prevention of ovarian hyperstimulation syndrome (OHSS): British Fertility Society policy and practice guideline.

Progesterone Primed Ovarian Stimulation (PPOS) vs. clomiphene Primed Ovarian Stimulation (CPOS) in high responder (HR) patients undergoing controlled ovarian stimulation. A Randomised Control trial.

Safety and effectiveness of dual trigger (GnRH agonist + HCG) versus HCG alone in patients with high ovarian response.

Efficacy of Local N-Acetylcysteine Administration in Mitigating OHSS Parameters: A Comparative Analysis With Dopaminergic Agonist in the OHSS Model.

Fractalkine/CX3CL1 and macrophage inflammatory protein- 1β/CCL4 activity in the rat ovary with induced ovarian hyperstimulation.

Reduction of Ovarian Cysts After Endoscopic Surgery for Follicle-Stimulating Hormone-Producing Pituitary Adenoma.

Ovarian Hyperstimulation and Maternal Virilisation with Successful Pregnancy Outcome: A case report.

Recurrent spontaneous ovarian hyperstimulation in a young nonpregnant Chinese woman with Rathke cleft cyst and a KISS1R variant: A rare case report and literature review.

Efficacy of acupuncture for pregnancy with early-onset ovarian hyperstimulation syndrome: study protocol for a randomised controlled clinical trial.

Role of In Vitro Fertilization (IVF) in Unexplained Infertility Management: A Systematic Review.

mTOR inhibitors as potential therapeutics for endometriosis: a narrative review.

Triggering oocyte maturation in in vitro fertilization treatment in healthy responders: a systematic review and network meta-analysis.

Identification and Characterization of Novel FSHR Copy Number Variations Causing Premature Ovarian Insufficiency.

Fixed versus flexible gonadotropin releasing hormone antagonist protocol in women with polycystic ovary syndrome undergoing in vitro fertilization: An RCT.

A simple and practical approach to elective egg freezing to control costs and expand access to care.

A repeated gonadotropin-releasing hormone agonist trigger improves pregnancy outcomes of frozen-thawed embryo transfer in GnRH antagonist cycles: a retrospective propensity-matched score analysis.

The role of letrozole in in vitro fertilization treatment: new remedy or old mirage?

Case 330: Ovarian Torsion in the Setting of Ovarian Hyperstimulation Syndrome.

Estradiol-to-follicle ratio on human chorionic gonadotropin day is a novel predictor of gestational diabetes mellitus in women receiving fresh embryo transfer.

Lupus activity and pregnancy outcomes in systemic lupus erythematosus patients undergoing assisted reproductive therapy: A systematic review and meta-analysis.

Recent developments in drug treatment strategies for infertility in patients with polycystic ovary syndrome.

In vitro maturation of oocytes: what is already known?†.

Relationship between CCL25/CCR9 Levels in Follicular Fluid and High Ovarian Response in Patients with Polycystic Ovary Syndrome.

The good, the bad and the ugly of luteal phase stimulations.

[Fertility preservation in patients with hematopoietic diseases].

The clinical diversity of primary hypothyroidism presenting as a spontaneous ovarian hyperstimulation syndrome.

Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications.